Patent intelligence · US
US 2012076825
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
Patent details — US 2012076825
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 29, 2012
- Expiration
- Mar 24, 2032
- Applicant
- WEBSTER HEATHER MICHELLE [US]
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 20 A I, A61K 35/ 12 A I, A61K 35/ 64 A I
Quick answer
US 2012076825 (PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF) is held by WEBSTER HEATHER MICHELLE [US]. Status: granted. Granted Mar 29, 2012. Expires Mar 24, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- WEBSTER HEATHER MICHELLE [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 20 A I, A61K 35/ 12 A I, A61K 35/ 64 A I, A61K 35/ 646 A I, A61K 39/ 35 A I
More from WEBSTER HEATHER MICHELLE [US]
Related pharmaceutical patents in our USPTO index.
-
WO 2024200854
ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE
granted -
EP 4302751
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
granted -
EP 4302750
ORALE DÜNNFILME ENTHALTEND ADRENALIN
granted -
CA 3259886
DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
CA 3255134
COMPOSITION D'ALLERGÈNE D'ARACHIDE
granted -
WO 2019224246
MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE
granted -
HK 1249412
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
granted
Frequently asked questions
What is US patent 2012076825?
US 2012076825 (PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF) is held by WEBSTER HEATHER MICHELLE [US]. Status: granted. Granted Mar 29, 2012. Expires Mar 24, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2012076825?
WEBSTER HEATHER MICHELLE [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2012076825 expire?
Our index shows an expiration date of Mar 24, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.